Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus. 1992

S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
Unité de Recombinaison et Expression Génétique, Institut Pasteur, Paris, France.

Two murine monoclonal antibodies (MAbs), designated MATG2014 and MATG2033, were generated. They are reactive with the external envelope glycoprotein gp130 of the simian immunodeficiency virus of macaque monkey (SIVmac251), and display a cell-free virus neutralizing activity in vitro. In addition, MATG2014 cross-reacts with HIV-2Rod gp140. Epitope mapping of these MAbs was performed by screening and SIVmac peptide library expressed in yeast and confirmed using synthetic peptides. MATG2014 and MATG2033 recognize two overlapping epitopes localized in an 18 residue domain between amino acid 171 and 188 of the SIVmac251 gp130. Sera from experimentally SIV-infected macaques are immunoreactive with this neutralizing domain. Sequence comparison with related SIV and HIV-2 viral strains indicates a low variability of this region, consistent with the cross-reactivity of MATG2014 with HIV-2Rod gp140. This domain should then be considered in designing experimental vaccines.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian

Related Publications

S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
November 2000, Virology,
S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
December 1997, Journal of virology,
S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
February 1994, Journal of virology,
S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
July 1994, Journal of chromatography. A,
S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
May 1995, Journal of medical primatology,
S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
November 1995, Biochemistry,
S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
December 1998, Virology,
S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
June 1992, AIDS research and human retroviruses,
S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
October 1998, Journal of virology,
S Benichou, and R Legrand, and N Nakagawa, and T Faure, and F Traincard, and G Vogt, and D Dormont, and P Tiollais, and M P Kieny, and P Madaule
May 2008, Virology,
Copied contents to your clipboard!